Milestone Pharmaceuticals Inc (MIST)
1.74
-0.01
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
1.74
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Total Liabilities (Quarterly): 56.08M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 56.08M |
| December 31, 2023 | 58.46M |
| September 30, 2023 | 58.61M |
| June 30, 2023 | 56.61M |
| March 31, 2023 | 57.14M |
| December 31, 2022 | 8.135M |
| September 30, 2022 | 8.614M |
| June 30, 2022 | 4.64M |
| March 31, 2022 | 5.043M |
| December 31, 2021 | 7.249M |
| September 30, 2021 | 6.359M |
| Date | Value |
|---|---|
| June 30, 2021 | 5.901M |
| March 31, 2021 | 6.451M |
| December 31, 2020 | 6.855M |
| September 30, 2020 | 6.599M |
| June 30, 2020 | 5.123M |
| March 31, 2020 | 5.524M |
| December 31, 2019 | 8.511M |
| September 30, 2019 | 9.06M |
| June 30, 2019 | 6.524M |
| March 31, 2019 | 143.01M |
| December 31, 2018 | 143.29M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.64M
Minimum
Jun 2022
58.61M
Maximum
Sep 2023
19.37M
Average
7.052M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.00M |
| Shareholders Equity (Quarterly) | 39.92M |